StockData

POMDOCTOR Ltd (POM) stock

POMNasdaqRetail-Miscellaneous RetailFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 14, 2026Score 1/30
$1.66+0.06 (+3.75%)

Close on Nov 11, 2026Market cap $230.90MP/E –Yield –

POMDOCTOR Ltd grew revenue 16.7% to CN¥399.91M over fiscal 2025. Free cash flow was -CN¥149.49M. At the latest close the market valued the company at CN¥1.54B.

Revenue
CN¥399.91M
+16.7% vs. a year earlier
Operating income
-CN¥118.63M
FY2025
Free cash flow
-CN¥149.49M
FY2025
EPS, diluted
-21.96 CNY
FY2025

Key statistics

Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026

Valuation

Market cap
CN¥1.54B
P/E ratio
–
Price to sales
3.85
Price to book
–
Dividend yield
–
Free cash flow yield
-9.70%

Fundamentals

Revenue
CN¥399.91M
EPS, diluted
-21.96 CNY
Free cash flow
-CN¥149.49M

Trading

Previous close
$1.60
Open
$1.60
Day's range
$1.55 – $1.66
Volume
61,575
Average volume (20 days)
3,337,560
RSI (14 days)
57.6
Volatility (1 year)
261.4%
Relative volume
0.08×

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

PeriodPOMS&P 500DifferencePOM per yearS&P 500 per year
1 month+115.6%-2.4%+118.0 pts
3 months+62.7%-1.2%+63.9 pts
Year to date-68.7%+12.3%−81.0 pts
1 year-98.3%+12.4%−110.7 pts

Four years at a glance

Fiscal years 2022 to 2025, CNY

Revenue

CN¥399.91M+16.7% YoY

Gross profit

CN¥52.28M+9.6% YoY

Operating income

-CN¥118.63M

EPS, diluted

-21.96 CNY

Free cash flow

-CN¥149.49M
Reported period

Press releases

Releases Pomdoctor filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Pomdoctor

Retail-Miscellaneous Retail

PomDoctor Limited operates a digital healthcare and pharmaceutical platform in China, connecting registered patients with doctors. The company facilitates medical prescription diagnoses, online doctor consultations, and treatments conducted by contracted healthcare professionals. In addition to telehealth services, the platform enables transacting patients to order and purchase pharmaceutical products, medical devices, and health-related items online, supported by requisite pharmaceutical, food, and internet drug information licenses.

Company profile, executives and history

Pomdoctor stock: common questions

What is Pomdoctor's stock price?

POM closed at $1.66 on Nov 11, 2026, up 3.75% on the day.

What is Pomdoctor's market cap?

Pomdoctor was worth $230.90M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.

What is POM's P/E ratio?

Pomdoctor lost money over fiscal 2025 (diluted EPS -21.96 CNY), so it has no meaningful P/E ratio.

How much revenue does Pomdoctor make?

Pomdoctor reported revenue of CN¥399.91M for fiscal 2025, up 16.7% from a year earlier.

Does Pomdoctor pay a dividend?

No. Pomdoctor has not paid a cash dividend over the last twelve months.

How has POM stock performed over the past year?

Including dividends, POM returned -98.3% over the past year, against +12.4% for the S&P 500.

Who are Pomdoctor's competitors?

Companies most similar to Pomdoctor by business, industry and size include BQ, JWEL, YJ, REAL, RDGT.

See a number that looks wrong?